38 related articles for article (PubMed ID: 6285812)
1. Clinical and pathological evaluation of sulbactam/ampicillin for treatment of experimental bovine pneumonic pasteurellosis.
Gifford GA; Potter AA; Babiuk LA
Can Vet J; 1988 Feb; 29(2):142-8. PubMed ID: 17422967
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and therapeutic trial of sultamicillin in acute sinusitis.
Jones S; Yu VL; Johnson JT; Wagner RL; Kim HK
Antimicrob Agents Chemother; 1985 Dec; 28(6):832-3. PubMed ID: 3002247
[TBL] [Abstract][Full Text] [Related]
3. In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria.
Wexler HM; Harris B; Carter WT; Finegold SM
Antimicrob Agents Chemother; 1985 May; 27(5):876-8. PubMed ID: 2990330
[TBL] [Abstract][Full Text] [Related]
4. Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.
Campoli-Richards DM; Brogden RN
Drugs; 1987 Jun; 33(6):577-609. PubMed ID: 3038500
[TBL] [Abstract][Full Text] [Related]
5. Worldwide clinical experience with sultamicillin.
Pitts NE; Gilbert GS; Knirsch AK; Noguchi Y
APMIS Suppl; 1989; 5():23-34. PubMed ID: 2660868
[TBL] [Abstract][Full Text] [Related]
6. Treatment of infections caused by ampicillin-resistant pathogens with a combination of ampicillin and CP-45,899.
Plouffe JF
Antimicrob Agents Chemother; 1982 Mar; 21(3):519-20. PubMed ID: 6285812
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of sulbactam/ampicillin in pediatric infections caused by ampicillin-resistant or penicillin-resistant organisms.
Syriopoulou V; Bitsi M; Theodoridis C; Saroglou I; Krikos X; Tzanetou K
Rev Infect Dis; 1986; 8 Suppl 5():S630-3. PubMed ID: 3026016
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of beta-lactamase-induced resistance in soft-tissue infections.
Nichols RL; Smith JW; Adinolfi MF; Galli R; Vivoda LM
Arch Surg; 1985 Jan; 120(1):36-42. PubMed ID: 2981523
[TBL] [Abstract][Full Text] [Related]
9. Sulbactam/ampicillin versus cefoxitin in the treatment of obstetric and gynaecological infections.
Senft HH; Stiglmayer R; Eibach HW; Koerner H
Drugs; 1986; 31 Suppl 2():18-21. PubMed ID: 3013568
[TBL] [Abstract][Full Text] [Related]
10. Sulbactam/ampicillin for treatment of polymicrobial pelvic infections.
Hemsell DL
Drugs; 1986; 31 Suppl 2():22-5. PubMed ID: 3013569
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy and safety of sulbactam/ampicillin in patients suffering from chronic liver disease.
Galante D; Esposito S; Barba D; Ruffilli MP
J Antimicrob Chemother; 1987 Apr; 19(4):527-32. PubMed ID: 3034850
[TBL] [Abstract][Full Text] [Related]
12. Interaction of clindamycin and gentamicin in vitro.
Fass RJ; Rotilie CA; Prior RB
Antimicrob Agents Chemother; 1974 Nov; 6(5):582-7. PubMed ID: 15825309
[TBL] [Abstract][Full Text] [Related]
13. CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and Bacteroides.
Retsema JA; English AR; Girard AE
Antimicrob Agents Chemother; 1980 Apr; 17(4):615-22. PubMed ID: 6249192
[TBL] [Abstract][Full Text] [Related]
14. Comparative inhibition beta-lactamases by novel beta-lactam compounds.
Fu KP; Neu HC
Antimicrob Agents Chemother; 1979 Feb; 15(2):171-6. PubMed ID: 311616
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]